Bausch Health Companies | Capitale Ordinario

Prezzo Delle Azioni
8.14
Cambio Giornaliero
0.05 0.62%
Mensile
4.76%
Annuale
-21.66%
Q1 Previsione
7.89




Capitale Ordinario Cambiamento Data
Amgen USD 539M 1000K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 6.98B 907K 2024-12
Bausch Health Companies USD 370.53M 59K 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 332.38M 127.23M 2025-09
Corcept Therapeutics USD 105.97M 842K 2025-12
Danaher USD 706.9M 600K 2025-12
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
Nektar Therapeutics USD 19K 0 2024-09
Novo Nordisk DKK 4.44B 0 2025-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Phibro Animal Health USD 4K 0 2024-09
Prestige Brands USD 48.08M 47.52M 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12
Zoetis USD 424.93M 16.54M 2025-12


Bausch Health Companies Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.